- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Oxidative stress and mitochondrial dysfunction in Kindler syndrome ; volume:9 ; number:1 ; day:21 ; month:12 ; year:2014 ; pages:1-10 ; date:12.2014
Orphanet journal of rare diseases ; 9, Heft 1 (21.12.2014), 1-10, 12.2014
- Creator
-
Zapatero-Solana, Elisabeth
- Contributor
-
García-Giménez, José Luis
Guerrero-Aspizua, Sara
García, Marta
Toll, Agustí
Baselga, Eulalia
Durán-Moreno, Maria
Markovic, Jelena
García Verdugo, José Manuel
Conti, Claudio J.
Has, Cristina
Larcher, Fernando
Pallardó, Federico V.
Del Rio, Marcela
SpringerLink (Online service)
- DOI
-
10.1186/s13023-014-0211-8
- URN
-
urn:nbn:de:1111-2016050126193
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zapatero-Solana, Elisabeth
- García-Giménez, José Luis
- Guerrero-Aspizua, Sara
- García, Marta
- Toll, Agustí
- Baselga, Eulalia
- Durán-Moreno, Maria
- Markovic, Jelena
- García Verdugo, José Manuel
- Conti, Claudio J.
- Has, Cristina
- Larcher, Fernando
- Pallardó, Federico V.
- Del Rio, Marcela
- SpringerLink (Online service)
Other Objects (12)
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Kindler syndrome in a patient with colitis and primary sclerosing cholangitis : : coincidence or association?
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Update on genetic conditions affecting the skin and the kidneys
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Selected genodermatoses – Status quo and future prospects
Treatment of epidermolysis bullosa and future directions: a review
Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Kindler syndrome in a patient with colitis and primary sclerosing cholangitis : : coincidence or association?
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Update on genetic conditions affecting the skin and the kidneys
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Selected genodermatoses – Status quo and future prospects
Treatment of epidermolysis bullosa and future directions: a review
Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Kindler syndrome in a patient with colitis and primary sclerosing cholangitis : : coincidence or association?
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Update on genetic conditions affecting the skin and the kidneys
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Selected genodermatoses – Status quo and future prospects
Treatment of epidermolysis bullosa and future directions: a review
Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency